DFH-29568-00396
4 vaccinations
7 coded responses
17 check-ins
7 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Moderna
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 2 — Moderna
-
2021-03-05
Health check-in — day 0, dose 2Feeling: Good · Site: Itching · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-19
-
2021-03-28
Survey response — day 21, dose 2MedDRA: Abdominal discomfort, Gastrooesophageal reflux disease, Migraine, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Migraine, vomiting, GERDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-02
-
2021-04-09
Survey response — day 35, dose 2MedDRA: Heavy menstrual bleeding, Menstruation delayed — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Had heavy menstruation the week after second shot. Delayed period now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-16
Survey response — day 42, dose 2MedDRA: Arthralgia, Heavy menstrual bleeding, Telemedicine — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Heavier and more painful menstruation. Relapse of PTSD (pain in joints from second shot was the trigger). Inflammation and finding in left breast. · Healthcare visit (other): In-person physical and mammogramMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-04
Survey response — 3 months, dose 2MedDRA: Breast inflammation, Lymphadenitis, Mammogram abnormal — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Inflammation of lymph nodes in arm where vaccine was given. Inflammation of breast tissue noted during mammogram.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-04
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-03
-
2021-12-16
Dose 3 — ModernaCo-administered: Flu
-
2021-12-20
Call successfulNot applicable - Accidental Reporting
-
2022-04-28
Dose 4 — Moderna
-
2022-04-29
Survey response — days 1–6 daily, dose 4MedDRA: Renal pain — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Kidney painMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2022-05-30
Survey response — day 28, dose 4MedDRA: Diplopia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Monocular diplopia in both eyes. Started intermittently in December after first booster, worsened significantly after second booster on 4/28/22MedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Report sent to call center — day 28, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-31
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-30
Survey response — 6 months, dose 4MedDRA: Anaemia, Cognitive disorder, Diplopia, Inflammation, Ocular discomfort, Office visit, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Severe inflammation, cognitive impairment, double vision (monocular diplopia), blurry vision, pressure behind eyes, tied to inflammation. New severe anemia. Symptoms coincide with onset at 1st Moderna booster, severity increase with 2nd. · Healthcare visit (other): Saw 3 Neurologists, RheumatologistMedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-31
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna | |
| 3 | 2021-12-16 | Moderna | Flu |
| 4 | 2022-04-28 | Moderna | No |
Call center
6 call center cases
6 successful
Free text
Release 6 — day 21, dose 2
Symptoms: Migraine, vomiting, GERD
Release 7 — day 35, dose 2
Symptoms: Had heavy menstruation the week after second shot. Delayed period now.
Release 7 — day 42, dose 2
Symptoms: Heavier and more painful menstruation. Relapse of PTSD (pain in joints from second shot was the trigger). Inflammation and finding in left breast.
Healthcare visit (other): In-person physical and mammogram
Release 8 — 3 months, dose 2
Symptoms: Inflammation of lymph nodes in arm where vaccine was given. Inflammation of breast tissue noted during mammogram.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Kidney pain
Release 11 — day 28, dose 4
Symptoms: Monocular diplopia in both eyes. Started intermittently in December after first booster, worsened significantly after second booster on 4/28/22
Release 12 — 6 months, dose 4
Symptoms: Severe inflammation, cognitive impairment, double vision (monocular diplopia), blurry vision, pressure behind eyes, tied to inflammation. New severe anemia. Symptoms coincide with onset at 1st Moderna booster, severity increase with 2nd.
Healthcare visit (other): Saw 3 Neurologists, Rheumatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Telemedicine | ✓ | ✓ | ✓ |
| SD | Abdominal discomfort | ○ | ✓ | ○ |
| SD | Anaemia | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Breast inflammation | ✓ | ✓ | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Diplopia | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Lymphadenitis | ✓ | ✓ | ✓ |
| SD | Mammogram abnormal | ✓ | ✓ | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Ocular discomfort | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Renal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release